Syneron Analyst Day Presentation

206 Pages·2015·12.48 MB·English

by  Tamar Raab

Energy
Injecting . Changing Lives.
Syneron Candela (NASDAQ: ELOS) | Analyst Day - December 3, 2015
Meeting Agenda
Dr. Shimon Eckhouse Syneron Overview
Amit Meridor Syneron Business Model
Jeff Nardoci Body Shaping Update
Dr. Zena Gabriel UltraShape / VelaShape
Dr. Reps Sundin UltraShape
Dr. Vic Narurkar PicoWay
Dr. Macrene Alexiades Profound
Q&A Q&A
Energy
Injecting . Changing Lives.
Syneron Candela (NASDAQ: ELOS) | Analyst Day - December 3, 2015
Safe Harbor For Forward Looking Statements
Any statements contained in this presentation regarding future expectations, projections, beliefs, goals, plans or
prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
1995. Further, any statements that are not statements of historical fact (including statements containing "believes,"
"anticipates," "plans," "expects," "may," "will,"L "weouald,d" "ienternsdsh," "iepstim iantes " and similar expressions) should also be
considered to be forward-looking statements. There are a number of important risks and factors that could cause
actual results or events to differ mAatereialsly tfhrome tthiocse Mindiecatdedi cbyi nthee forward-looking statements in this
presentation, including the risks set forth in Syneron Medical Ltd.'s most recent Annual Report on Form 20-F and
the other factors described in the filings that Syneron Medical Ltd. makes with the Securities and Exchange
Commission from time to time. If one or more of these risks or factors materialize, or if any underlying assumptions
prove incorrect, Syneron Medical Ltd.'s actual results, performance or achievements may vary materially from any
future results, performance or achievements expressed or implied by the forward-looking statements in this
presentation.
Syneron Candela at a Glance
A global leader in medical aesthetic devices
• Strongest global brand name in the physician and
professional aesthetic technology market
• Clear technology innovator with the widest range of patented
technologies (893 granted patents and patent applications)
• Diverse product portfolio and robust product pipeline
• Vast worldwide presence in sales, distribution, service
network and installed base
• Three technology solutions generating double digit growth in
underpenetrated markets

28% Worldwide ~$273M ~$80M in Cash³;

Market Share¹ Revenue² No Debt

1 Based on US publicly traded companies listed here (CYNO, CUTR, ZLTQ) for 3Q15; Professional Aesthetic Device Sector
2 Trailing twelve month revenue
³ September 30, 2015 Balance Sheet
The Global Aesthetic Market
2015 WW Sales of Aesthetic Products ($M)
% CAGR is for 2014 to 2019
$1,639 ( 10.9%)
$1,521 ( 8.8%)
$1,366 ( 9.2%)
$1,018 ( 15%) $998 ( 8.4%)
Energy based Body Shaping² & Neurotoxins Fillers Physician
devices¹ Liposuction Dispensed Topicals
Total 2015 market size $6.6B with a CAGR of 12% (2014-2019)
Energy Based Devices represent only 36% of the market
Source: Medical Insight, Inc.
¹ Includes Emerging Products
² Includes Skin Tightening
We Inject Energy!
Energy Based Treatments offer a highly effective solution for physicians and patients
• Address a wide range of facial aesthetic
conditions and areas (including wrinkles, skin
laxity, missing volume, skin rejuvenation,
pigment, texture and acne scars)
• Address a wide range of body aesthetic
conditions (including body shaping, fat
destruction, cellulite and skin laxity)
• Comfortable for patient, easy to use by doctor
or staff
• Just energy – no unnatural substances injected
• Significantly longer lasting results than fillers &
toxins
A Strategic Emphasis on Combined Business Models
Product Focus To-Date 2016 Going Forward
Capital equipment and service revenue Capital equipment, service and recurring revenue
Syneron Candela Three Leading Growth Engines
• UltraShape and VelaShape™
™ $30 Billion
Comprehensive suite of proven technologies for all non- Non-Invasive Body
Shaping Market
invasive Fat Destruction and Body Shaping treatments
in the US alone!

• PicoWay™ $13 Billion
Tattoo Removal
Breakthrough technology for Tattoo Removal,
Market
Pigmentation and Skin Rejuvenation
in the US alone!

• Profound™ $45 Billion
Facial Treatments
Innovative proven treatment of skin laxity, loss of volume
Market
and submental fat lipolysis
in the US alone!

Total Potential Treatments Market*

* Based on Syneron Candela proprietary consumer surveys, public information and internal estimates
PicoWay™ High End Facial Aesthetic Treatments
Dual wavelength, Highest peak power, Shortest picosecond pulses